1. Home
  2. Service & Software
  3. Global Pharmaceuticals and Biotechnology R&D Market Status and Forecast 2021-2027

Global Pharmaceuticals and Biotechnology R&D Market Status and Forecast 2021-2027

Publication Month: Sep 2021 | No. of Pages: 144 Published By: GRD Survey
Single User License: US $ 2980
Corporate User License: US $ 5960

This report provides a comprehensive analysis of current global Pharmaceuticals and Biotechnology R&D market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Pharmaceuticals and Biotechnology R&D industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Pharmaceuticals and Biotechnology R&D market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Pharmaceuticals and Biotechnology R&D Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceuticals and Biotechnology R&D market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Pharmaceuticals and Biotechnology R&D Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Pharmaceuticals and Biotechnology R&D industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Drug
Medical Equipment
Vaccine
Others

Segmented by Application
Hospital
Clinic
Homecare
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
TEVA PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL
SANOFI
ROCHE
PFIZER
NOVO NORDISK
NOVARTIS
MERCK
JOHNSON & JOHNSON
GLAXOSMITHKLINE
GILEAD SCIENCES
ELI LILLY
BRISTOL-MYERS SQUIBB
BOEHRINGER SOHN
BIOGEN
BAYER
ASTRAZENECA
ASTELLAS PHARMA
AMGEN
ABBVIE
ABBOTT


Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Pharmaceuticals and Biotechnology R&D Market Status and Forecast (2016-2027)
1.3.2 Global Pharmaceuticals and Biotechnology R&D Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Pharmaceuticals and Biotechnology R&D Supply by Company
2.1 Global Pharmaceuticals and Biotechnology R&D Sales Value by Company
2.2 Pharmaceuticals and Biotechnology R&D Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Pharmaceuticals and Biotechnology R&D Market Status by Type
3.1 Pharmaceuticals and Biotechnology R&D Type Introduction
3.1.1 Drug
3.1.2 Medical Equipment
3.1.3 Vaccine
3.1.4 Others
3.2 Global Pharmaceuticals and Biotechnology R&D Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Pharmaceuticals and Biotechnology R&D Market Status by Application
4.1 Pharmaceuticals and Biotechnology R&D Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Homecare
4.1.4 Others
4.2 Global Pharmaceuticals and Biotechnology R&D Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Pharmaceuticals and Biotechnology R&D Market Status by Region
5.1 Global Pharmaceuticals and Biotechnology R&D Market by Region
5.2 North America Pharmaceuticals and Biotechnology R&D Market Status
5.3 Europe Pharmaceuticals and Biotechnology R&D Market Status
5.4 Asia Pacific Pharmaceuticals and Biotechnology R&D Market Status
5.5 Central & South America Pharmaceuticals and Biotechnology R&D Market Status
5.6 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Status
6 North America Pharmaceuticals and Biotechnology R&D Market Status
6.1 North America Pharmaceuticals and Biotechnology R&D Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Pharmaceuticals and Biotechnology R&D Market Status
7.1 Europe Pharmaceuticals and Biotechnology R&D Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Pharmaceuticals and Biotechnology R&D Market Status
8.1 Asia Pacific Pharmaceuticals and Biotechnology R&D Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Pharmaceuticals and Biotechnology R&D Market Status
9.1 Central & South America Pharmaceuticals and Biotechnology R&D Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Status
10.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Type and by Application
12.1 Global Pharmaceuticals and Biotechnology R&D Sales Value Forecast (2022-2027)
12.2 Global Pharmaceuticals and Biotechnology R&D Forecast by Type
12.3 Global Pharmaceuticals and Biotechnology R&D Forecast by Application
13 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Region/Country
13.1 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 TEVA PHARMACEUTICAL INDUSTRIES
14.1.1 Company Information
14.1.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.1.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 TAKEDA PHARMACEUTICAL
14.2.1 Company Information
14.2.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.2.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 SANOFI
14.3.1 Company Information
14.3.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.3.3 SANOFI Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 ROCHE
14.4.1 Company Information
14.4.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.4.3 ROCHE Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 PFIZER
14.5.1 Company Information
14.5.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 NOVO NORDISK
14.6.1 Company Information
14.6.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.6.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 NOVARTIS
14.7.1 Company Information
14.7.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.7.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 MERCK
14.8.1 Company Information
14.8.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.8.3 MERCK Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 JOHNSON & JOHNSON
14.9.1 Company Information
14.9.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.9.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 GLAXOSMITHKLINE
14.10.1 Company Information
14.10.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 GILEAD SCIENCES
14.12 ELI LILLY
14.13 BRISTOL-MYERS SQUIBB
14.14 BOEHRINGER SOHN
14.15 BIOGEN
14.16 BAYER
14.17 ASTRAZENECA
14.18 ASTELLAS PHARMA
14.19 AMGEN
14.20 ABBVIE
14.21 ABBOTT
15 Conclusion
16 Methodology

Tables and Figures

List of Tables

Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Company (2019-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Pharmaceuticals and Biotechnology R&D Sales Area
Table Pharmaceuticals and Biotechnology R&D Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Type (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sals Value Market Share by Type (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Type (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Type (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Type (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Type (2016-2021)
Table Central & South America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Type (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Application (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share by Application (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Application (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Application (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Application (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Application (2016-2021)
Table Central & South America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Application (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Region (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share by Region (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Central & South America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Value (Million USD) Forecast by Type (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share Forecast by Type (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value (Million USD) Forecast by Application (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share Forecast by Application (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value (Million USD) Forecast by Region (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share Forecast by Region (2022-2027)
Table TEVA PHARMACEUTICAL INDUSTRIES Company Information
Table TEVA PHARMACEUTICAL INDUSTRIES Product Introduction
Table TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table TAKEDA PHARMACEUTICAL Company Information
Table TAKEDA PHARMACEUTICAL Product Introduction
Table TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table SANOFI Company Information
Table SANOFI Product Introduction
Table SANOFI Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table ROCHE Company Information
Table ROCHE Product Introduction
Table ROCHE Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table PFIZER Company Information
Table PFIZER Product Introduction
Table PFIZER Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table NOVO NORDISK Company Information
Table NOVO NORDISK Product Introduction
Table NOVO NORDISK Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table NOVARTIS Company Information
Table NOVARTIS Product Introduction
Table NOVARTIS Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table MERCK Company Information
Table MERCK Product Introduction
Table MERCK Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table JOHNSON & JOHNSON Company Information
Table JOHNSON & JOHNSON Product Introduction
Table JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table GLAXOSMITHKLINE Company Information
Table GLAXOSMITHKLINE Product Introduction
Table GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)


Reason to Buy

  • Current and future of Service & Software Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Service & Software Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets